HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.

Rabbits and monkeys immunized with HIV type 1 (HIV-1) native-like BG505 SOSIP.664 (BG505s) glycoprotein trimers are known to induce antibodies that can neutralize the autologous tier-2 virus. Here, we assessed the induction of HIV-1 trimer binding and neutralizing antibody (nAb) titres when BG505s t...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvia Capucci, Edmund G Wee, Torben Schiffner, Celia C LaBranche, Nicola Borthwick, Albert Cupo, Jonathan Dodd, Hansi Dean, Quentin Sattentau, David Montefiori, Per J Klasse, Rogier W Sanders, John P Moore, Tomáš Hanke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181886&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076670442078208
author Silvia Capucci
Edmund G Wee
Torben Schiffner
Celia C LaBranche
Nicola Borthwick
Albert Cupo
Jonathan Dodd
Hansi Dean
Quentin Sattentau
David Montefiori
Per J Klasse
Rogier W Sanders
John P Moore
Tomáš Hanke
author_facet Silvia Capucci
Edmund G Wee
Torben Schiffner
Celia C LaBranche
Nicola Borthwick
Albert Cupo
Jonathan Dodd
Hansi Dean
Quentin Sattentau
David Montefiori
Per J Klasse
Rogier W Sanders
John P Moore
Tomáš Hanke
author_sort Silvia Capucci
collection DOAJ
description Rabbits and monkeys immunized with HIV type 1 (HIV-1) native-like BG505 SOSIP.664 (BG505s) glycoprotein trimers are known to induce antibodies that can neutralize the autologous tier-2 virus. Here, we assessed the induction of HIV-1 trimer binding and neutralizing antibody (nAb) titres when BG505s trimers were also delivered by non-replicating simian (chimpanzee) adenovirus and non-replicating poxvirus modified vaccinia virus Ankara (MVA) vaccine vectors. First, we showed that approximately two-thirds and one-third of the trimers secreted from the ChAdOx1.BG505s (C) and MVA.BG505s (M) vaccine-infected cells, respectively, were cleaved and in a native-like conformation. Rabbits were immunized intramuscularly with these vaccine vectors and in some cases boosted with ISCOMATRIX™-adjuvanted BG505s protein trimer (P), using CCC, MMM, PPP, CPP, MPP and CMP vaccine regimens. We found that the peak trimer-binding antibody and tier-1A and autologous tier-2 nAb responses induced by the CC, CM, PPP, CPP, MPP and CMP regimens were comparable, although only PPP induced autologous tier-2 nAbs in all the immunized animals. Three animals developed weak heterologous tier-2 nAbs. These results demonstrate that ChAdOx1 and MVA vectors are useful delivery modalities for not only T-cell, but also antibody vaccine development.
format Article
id doaj-art-96b2207bc5b24d9496ecdec92ae9f12b
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-96b2207bc5b24d9496ecdec92ae9f12b2025-08-20T02:45:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018188610.1371/journal.pone.0181886HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.Silvia CapucciEdmund G WeeTorben SchiffnerCelia C LaBrancheNicola BorthwickAlbert CupoJonathan DoddHansi DeanQuentin SattentauDavid MontefioriPer J KlasseRogier W SandersJohn P MooreTomáš HankeRabbits and monkeys immunized with HIV type 1 (HIV-1) native-like BG505 SOSIP.664 (BG505s) glycoprotein trimers are known to induce antibodies that can neutralize the autologous tier-2 virus. Here, we assessed the induction of HIV-1 trimer binding and neutralizing antibody (nAb) titres when BG505s trimers were also delivered by non-replicating simian (chimpanzee) adenovirus and non-replicating poxvirus modified vaccinia virus Ankara (MVA) vaccine vectors. First, we showed that approximately two-thirds and one-third of the trimers secreted from the ChAdOx1.BG505s (C) and MVA.BG505s (M) vaccine-infected cells, respectively, were cleaved and in a native-like conformation. Rabbits were immunized intramuscularly with these vaccine vectors and in some cases boosted with ISCOMATRIX™-adjuvanted BG505s protein trimer (P), using CCC, MMM, PPP, CPP, MPP and CMP vaccine regimens. We found that the peak trimer-binding antibody and tier-1A and autologous tier-2 nAb responses induced by the CC, CM, PPP, CPP, MPP and CMP regimens were comparable, although only PPP induced autologous tier-2 nAbs in all the immunized animals. Three animals developed weak heterologous tier-2 nAbs. These results demonstrate that ChAdOx1 and MVA vectors are useful delivery modalities for not only T-cell, but also antibody vaccine development.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181886&type=printable
spellingShingle Silvia Capucci
Edmund G Wee
Torben Schiffner
Celia C LaBranche
Nicola Borthwick
Albert Cupo
Jonathan Dodd
Hansi Dean
Quentin Sattentau
David Montefiori
Per J Klasse
Rogier W Sanders
John P Moore
Tomáš Hanke
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
PLoS ONE
title HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
title_full HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
title_fullStr HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
title_full_unstemmed HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
title_short HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
title_sort hiv 1 neutralizing antibody induced by simian adenovirus and poxvirus mva vectored bg505 native like envelope trimers
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181886&type=printable
work_keys_str_mv AT silviacapucci hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT edmundgwee hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT torbenschiffner hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT celiaclabranche hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT nicolaborthwick hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT albertcupo hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT jonathandodd hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT hansidean hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT quentinsattentau hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT davidmontefiori hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT perjklasse hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT rogierwsanders hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT johnpmoore hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers
AT tomashanke hiv1neutralizingantibodyinducedbysimianadenovirusandpoxvirusmvavectoredbg505nativelikeenvelopetrimers